{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:55:15Z","timestamp":1791276915991,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40618-014-0098-1","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T18:33:21Z","timestamp":1402425201000},"page":"729-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Altered expression of 3-betahydroxysterol delta-24-reductase\/selective Alzheimer\u2019s disease indicator-1 gene in Huntington\u2019s disease models"],"prefix":"10.1007","volume":"37","author":[{"given":"Athina","family":"Samara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarita","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Deledda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Messi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"98_CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/323473","volume":"69","author":"H Waterham","year":"2001","unstructured":"Waterham H, Koster J, Romeijn G et al (2001) Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69:685\u2013694","journal-title":"Am J Hum Genet"},{"key":"98_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00008480-200312000-00011","volume":"15","author":"FD Porter","year":"2003","unstructured":"Porter FD (2003) Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr 15:607\u2013613","journal-title":"Curr Opin Pediatr"},{"key":"98_CR3","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1523\/JNEUROSCI.20-19-07345.2000","volume":"20","author":"I Greeve","year":"2000","unstructured":"Greeve I, Hermans-Borgmeyer I, Brellinger C et al (2000) The human DIMINUTO\/DWARF1 homolog seladin-1 confers resistance to Alzheimer\u2019s disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345\u20137352","journal-title":"J Neurosci"},{"key":"98_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.emboj.7600938","volume":"25","author":"A Crameri","year":"2006","unstructured":"Crameri A, Biondi E, Kuehnle K et al (2006) The role of seladin-1\/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 25:432\u2013443","journal-title":"EMBO J"},{"key":"98_CR5","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1582-4934.2008.00216.x","volume":"12","author":"C Cecchi","year":"2008","unstructured":"Cecchi C, Rosati F, Pensalfini A et al (2008) Seladin-1\/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. J Cell Mol Med 12:1990\u20132002","journal-title":"J Cell Mol Med"},{"key":"98_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/MCB.00584-07","volume":"28","author":"K Kuehnle","year":"2008","unstructured":"Kuehnle K, Crameri A, K\u00e4lin R et al (2008) Prosurvival effect of DHCR24\/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol 28:539\u2013550","journal-title":"Mol Cell Biol"},{"key":"98_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/JME-08-0071","volume":"41","author":"A Peri","year":"2008","unstructured":"Peri A, Serio M (2008) Neuroprotective effects of the Alzheimer\u2019s disease-related gene seladin-1. J Mol Endocrinol 41:251\u2013261","journal-title":"J Mol Endocrinol"},{"key":"98_CR8","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1210\/en.2008-0024","volume":"149","author":"X Lu","year":"2008","unstructured":"Lu X, Kambe F, Cao X et al (2008) 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 149:3267\u20133273","journal-title":"Endocrinology"},{"key":"98_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuroscience.2011.03.011","volume":"191","author":"A Peri","year":"2011","unstructured":"Peri A, Benvenuti S, Luciani P, Deledda C, Cellai I (2011) Membrane cholesterol as a mediator of the neuroprotective effects of estrogens. Neuroscience 191:107\u2013117","journal-title":"Neuroscience"},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"405194","DOI":"10.1155\/2011\/405194","volume":"2011","author":"T Numakawa","year":"2011","unstructured":"Numakawa T, Matsumoto T, Numakawa Y, Richards M, Yamawaki S, Kunugi H (2011) Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J Toxicol 2011:405194","journal-title":"J Toxicol"},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2012-111955","volume":"30","author":"LJ Sharpe","year":"2012","unstructured":"Sharpe LJ, Wong J, Garner B, Halliday GM, Brown AJ (2012) Is seladin-1 really a selective Alzheimer\u2019s disease indicator? J Alzheimers Dis 30:35\u201339","journal-title":"J Alzheimers Dis"},{"key":"98_CR12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington Disease Collaborative Research","year":"1993","unstructured":"The Huntington Disease Collaborative Research (1993) G. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"98_CR13","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C et al (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20:3705\u20133713","journal-title":"J Neurosci"},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1074\/jbc.C100044200","volume":"276","author":"D Rigamonti","year":"2001","unstructured":"Rigamonti D, Sipione S, Goffredo D, Zuccato C, Fossale E, Cattaneo E (2001) Huntingtin\u2019s neuroprotective activity occurs via inhibition of procaspase-9 processing. J Biol Chem 276:14545\u201314548","journal-title":"J Biol Chem"},{"key":"98_CR15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"98_CR16","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh N, Moutereau S, Durr A et al (2009) Neuroendocrine disturbances in Huntington\u2019s disease. PLoS One 4:e4962","journal-title":"PLoS One"},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","volume":"24","author":"A Peters\u00e9n","year":"2006","unstructured":"Peters\u00e9n A, Bj\u00f6rkqvist M (2006) Hypothalamic-endocrine aspects in Huntington\u2019s disease. Eur J Neurosci 24:961\u2013967","journal-title":"Eur J Neurosci"},{"key":"98_CR18","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxid Redox Signal 8:2061\u20132073","journal-title":"Antioxid Redox Signal"},{"key":"98_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24:182\u2013188","journal-title":"Trends Neurosci"},{"key":"98_CR20","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","volume":"11","author":"S Sipione","year":"2002","unstructured":"Sipione S, Rigamonti D, Valenza M et al (2002) Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 11:1953\u20131965","journal-title":"Hum Mol Genet"},{"key":"98_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","volume":"28","author":"M Valenza","year":"2007","unstructured":"Valenza M, Leoni V, Tarditi A et al (2007) Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 28:133\u2013142","journal-title":"Neurobiol Dis"},{"key":"98_CR22","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM et al (2010) Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci 30:10844\u201310850","journal-title":"J Neurosci"},{"key":"98_CR23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","volume":"494","author":"V Leoni","year":"2011","unstructured":"Leoni V, Mariotti C, Nanetti L et al (2011) Whole body cholesterol metabolism is impaired in Huntington\u2019s disease. Neurosci Lett 494:245\u2013249","journal-title":"Neurosci Lett"},{"key":"98_CR24","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D et al (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci 25:9932\u20139939","journal-title":"J Neurosci"},{"key":"98_CR25","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","volume":"131","author":"V Leoni","year":"2008","unstructured":"Leoni V, Mariotti C, Tabrizi SJ et al (2008) Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease. Brain 131:2851\u20132859","journal-title":"Brain"},{"key":"98_CR26","doi-asserted-by":"crossref","first-page":"11845","DOI":"10.1074\/jbc.M900639200","volume":"284","author":"G Ermak","year":"2009","unstructured":"Ermak G, Hench KJ, Chang KT, Sachdev S, Davies KJ (2009) Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro. J Biol Chem 284:11845\u201311853","journal-title":"J Biol Chem"},{"key":"98_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"98_CR28","doi-asserted-by":"crossref","first-page":"24554","DOI":"10.1074\/jbc.M609885200","volume":"282","author":"D Rigamonti","year":"2007","unstructured":"Rigamonti D, Bolognini D, Mutti C et al (2007) Loss of huntingtin function complemented by small molecules acting as repressor element 1\/neuron restrictive silencer element silencer modulators. J Biol Chem 282:24554\u201324562","journal-title":"J Biol Chem"},{"key":"98_CR29","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45","journal-title":"Nucleic Acids Res"},{"key":"98_CR30","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO et al (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"98_CR31","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T et al (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"98_CR32","doi-asserted-by":"crossref","unstructured":"Quinti L, Chopra V, Rotili D, et al. (2010) Evaluation of histone deacetylases as drug targets in Huntington\u2019s disease models. Study of HDACs in brain tissues from R6\/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model. PLoS Curr 2. doi: 10.1371\/currents.RRN1172","DOI":"10.1371\/currents.RRN1172"},{"key":"98_CR33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","volume":"88","author":"KR Bowles","year":"2012","unstructured":"Bowles KR, Brooks SP, Dunnett SB, Jones L (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88:276\u2013284","journal-title":"Brain Res Bull"},{"key":"98_CR34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","volume":"89","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP, Keller C (2008) Del Pilar Amaya M. Neuropathology of Huntington\u2019s disease. Handb Clin Neurol 89:599\u2013618","journal-title":"Handb Clin Neurol"},{"key":"98_CR35","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A et al (2007) Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845\u20131861","journal-title":"Hum Mol Genet"},{"key":"98_CR36","doi-asserted-by":"crossref","unstructured":"Sarchielli E, Marini M, Ambrosini S, et al. (2014) Multifaceted roles of BDNF and FGF2 in human striatal primordium development. An in vitro study. Exp Neurol 257C:130\u2013147","DOI":"10.1016\/j.expneurol.2014.04.021"},{"key":"98_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0309-253","volume":"15","author":"M Katsuno","year":"2009","unstructured":"Katsuno M, Adachi H, Sobue G (2009) Getting a handle on Huntington\u2019s disease: the case for cholesterol. Nat Med 15:253\u2013254","journal-title":"Nat Med"},{"key":"98_CR38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature03173","volume":"432","author":"C Wu","year":"2004","unstructured":"Wu C, Miloslavskaya I, Demontis S, Maestro R, Galaktionov K (2004) Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432:640\u2013645","journal-title":"Nature"},{"key":"98_CR39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/ATVBAHA.109.184663","volume":"29","author":"K McGrath","year":"2009","unstructured":"McGrath K, Li X, Puranik R et al (2009) Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 29:877\u2013882","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"98_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jsbmb.2008.03.010","volume":"109","author":"M Otis","year":"2008","unstructured":"Otis M, Battista M, Provencher M et al (2008) From integrative signalling to metabolic disorders. J Steroid Biochem Mol Biol 109:224\u2013229","journal-title":"J Steroid Biochem Mol Biol"},{"key":"98_CR41","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1210\/jcem.86.11.8032","volume":"86","author":"D Sarkar","year":"2001","unstructured":"Sarkar D, Imai T, Kambe F et al (2001) The human homolog of Diminuto\/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas. J Clin Endocrinol Metab 86:5130\u20135137","journal-title":"J Clin Endocrinol Metab"},{"key":"98_CR42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20111495","volume":"446","author":"JI Chae","year":"2012","unstructured":"Chae JI, Kim DW, Lee N et al (2012) Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington\u2019s disease patient. Biochem J 446:359\u2013371","journal-title":"Biochem J"},{"key":"98_CR43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12031-011-9516-4","volume":"45","author":"JL Illuzzi","year":"2011","unstructured":"Illuzzi JL, Vickers CA, Kmiec EB (2011) Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin. J Mol Neurosci 45:256\u2013268","journal-title":"J Mol Neurosci"},{"key":"98_CR44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"98_CR45","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"98_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archpsyc.55.3.215","volume":"55","author":"G Rajkowska","year":"1998","unstructured":"Rajkowska G, Selemon LD, Goldman-Rakic PS (1998) Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 55:215\u2013224","journal-title":"Arch Gen Psychiatry"},{"key":"98_CR47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2009.05917.x","volume":"109","author":"K Nieweg","year":"2009","unstructured":"Nieweg K, Schaller H, Pfrieger FW (2009) Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem 109:125\u2013134","journal-title":"J Neurochem"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0098-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0098-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T11:39:52Z","timestamp":1565523592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0098-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0098-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}